05/02/2024 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
04/30/2024 12:11 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 8:47 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/29/2024 8:49 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
|
04/29/2024 8:55 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/26/2024 7:45 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 7:19 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 7:24 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/27/2024 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024 5:00 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
03/18/2024 3:31 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
02/28/2024 3:14 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/28/2024 3:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/28/2024 3:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/23/2024 12:25 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:47 PM | Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) Ionic Ventures, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 1:42 PM | ARMISTICE CAPITAL, LLC (Filed by) Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 1:14 PM | Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
02/12/2024 3:30 PM | Bigger Capital, LLC (Filed by) Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024 7:51 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2023 11:10 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/28/2023 3:30 PM | Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) Cavalry Fund I LP (Filed by)
| Form SC 13G | |
12/26/2023 3:51 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/26/2023 3:53 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/26/2023 3:53 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/21/2023 3:30 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 3:54 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B4 | |
12/18/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
12/14/2023 4:20 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
12/06/2023 4:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
12/06/2023 3:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023 7:57 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
11/27/2023 7:45 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2023 3:06 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
10/03/2023 9:10 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023 3:45 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2023 3:23 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023 3:21 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad) While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk.
As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires.
And it's all thanks to Musk's latest AI creation. Click to watch this device in action |
07/24/2023 3:22 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023 7:07 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023 7:27 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 3:43 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 10:52 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/26/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/22/2023 3:33 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2023 3:30 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
06/20/2023 7:16 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023 7:41 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
06/15/2023 3:51 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023 7:35 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/02/2023 5:00 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/01/2023 6:27 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023 3:24 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/25/2023 8:53 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
05/25/2023 8:54 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
05/25/2023 4:25 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
05/25/2023 3:39 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
05/25/2023 3:46 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
05/24/2023 4:29 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/18/2023 8:00 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |